Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Lawmakers Issue Dx Reform Bill To Strike Regulatory Balance

Mar 06 2020

• By Ferdous Al-Faruque

WASHINGTON, DC - MAY 20, 2019: US SENATOR RICHARD M BURR NORTH CAROLINA - office entrance sign

Related Content

Expect FDA Diagnostics-Reform Bill Passage In 2019, Rep. DeGette Says

Jan 16 2019

ACLA Rejects FDA As A ‘Clinical Validity’ Judge, While AdvaMedDx Seeks Tweaks To VALID Act

Feb 22 2019

Unfinished Business: LDT Legislation A Top Priority For Departing FDA Chief Gottlieb

Mar 22 2019

FDA Passes The Buck On LDTs, But Floats Ideas

Jan 13 2017

Additional Topics

United States Regulation Policy Approvals Compliance Enforcement FDA Guidance Documents Safety In Vitro Diagnostics Quality Control Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

About UsOpens in new window
Meet the Team
Advertise with us
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

Publications

Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window